Clinical Trials Logo

Pain, Acute clinical trials

View clinical trials related to Pain, Acute.

Filter by:

NCT ID: NCT03927781 Completed - Anesthesia Clinical Trials

Perioperative Pregabalin in Ureteroscopy: a Pilot

Start date: April 1, 2019
Phase: Phase 3
Study type: Interventional

The investigators propose a pilot clinical trial on the use of perioperative pregabalin in order to decrease ureteral stent related symptoms and decrease opioid usage after ureteroscopy with stent placement. Patients undergoing ureteroscopy with stent placement will receive a single dose of 300 mg pregabalin PO in the preoperative area. This work will assess safety and feasibility of studying this regimen at our institution, with the aim of performing a randomized, placebo-controlled, double-blinded study in the future.

NCT ID: NCT03893175 Completed - Pain, Acute Clinical Trials

Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction

Start date: May 10, 2019
Phase: Phase 1
Study type: Interventional

This research study will evaluate inter-individual variability in the analgesic response to the non-steroidal anti-inflammatory drug (NSAID) ibuprofen after third molar extraction surgery. It will also investigate demographic, clinical, genetic, and environmental factors that cause this variability.

NCT ID: NCT03881982 Completed - Pain, Acute Clinical Trials

A Novel Electronic Method of Collecting Pain Scores in the Emergency Department

PIMPERNEL
Start date: August 3, 2017
Phase: N/A
Study type: Interventional

Can a novel electronic display of pain be successfully used in the emergency department and does it (1) change analgesic prescription and (2) change amount of pain experienced? Pain is a common symptom in emergency care. As patients are seldom reassessed, staff may not be aware of pain. Currently, members of nursing or medical staff need to ask patients about their pain and record it manually using a visual analogue scale from 0-10. The new electronic display uses buttons to represent a pain scale from 0 (no pain) to 10 (worst pain). Patients will select the number that best corresponds to their pain every 15 minutes. In the experimental group, the score will be displayed on a screen. In the control group, the score will not be displayed. The investigators will compare the overall amount of pain in both groups, and will look at their pain management (painkillers prescribed). The investigators will also ask patients and staff for their opinions on the display. The study will include adult patients in the emergency department at Leicester Royal Infirmary with an initial pain score of 5 or more who are able to make a decision about whether to participate. Participants will also need to be likely to stay in the hospital for more than 2 hours to allow the investigators to gather enough useful data. The study will recruit 200 participants. If the study can demonstrate that the monitor is acceptable to patients and staff and results in improved pain management, it is a low cost intervention which could be widely implemented within the NHS. It also has the potential for being used in other areas such as surgical wards. The investigators have previously found that 300-400 patients per week in the department have moderate to severe pain and might therefore benefit from this monitor.

NCT ID: NCT03877146 Completed - Breast Cancer Clinical Trials

Calming Alternatives Learned During MRI-Guided Breast Biopsy

CALM
Start date: October 16, 2018
Phase: N/A
Study type: Interventional

The proposed randomized study evaluates whether a controlled breathing intervention could be efficacious for reducing pain in the MRI-guided breast biopsy setting. Support for this intervention stems from experimental and clinical studies on the effects of controlled breathing on pain. Implementing a controlled breathing intervention during MRI-guided breast biopsy has the potential to provide effective pain management in this outpatient setting. The primary study objectives are to assess the feasibility, acceptability, and efficacy of a novel audio-recorded controlled breathing intervention for reducing breast and body pain in women undergoing MRI-guided breast biopsy. The secondary study objectives are to evaluate the effects of controlled breathing on measures of physiological reactivity (i.e., blood pressure and heart rate), pain catastrophizing, and self-efficacy for pain and anxiety.

NCT ID: NCT03868436 Completed - Pain, Acute Clinical Trials

PENTHROX™ in the Canadian Emergency Department (ED)

ADVANCE-ED
Start date: April 8, 2019
Phase: Phase 4
Study type: Interventional

This Canadian, multi-centre, prospective, real world study is designed to evaluate the effectiveness of low dose methoxyflurane (MEOF) (PENTHROX™) for the treatment of moderate to severe pain associated with trauma in the Canadian ED.

NCT ID: NCT03852459 Completed - Pain, Acute Clinical Trials

Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS

Start date: January 12, 2018
Phase: Phase 2
Study type: Interventional

Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibuprofen Topical Gel 5%

NCT ID: NCT03798899 Completed - Pain, Acute Clinical Trials

Efficacy and Safety of Penthrox® Combined With a Standard Analgesia (SoC) in Adult Patients Admitted to the Emergency Department With Moderate to Severe Pain Associated With Trauma

Pen ASAP
Start date: May 14, 2018
Phase: Phase 4
Study type: Interventional

A phase 4 randomised, double-blind study to assess the efficacy and safety of Penthrox® used from the outset in multimodal analgesia, in combination with the standard analgesic protocol used in the department, for conscious adult patients presenting in an emergency department with moderate to severe pain associated with a trauma

NCT ID: NCT03781570 Completed - Pain, Acute Clinical Trials

Brain and Genetic Predictors of Individual Differences in Pain and Analgesia

PAINGEN
Start date: November 7, 2018
Phase:
Study type: Observational

The purpose of the study is to gain a better understanding of pain processing in the brain. Our understanding of how pain is processed in the brain is limited. We are testing for individual differences in pain perception and emotion.

NCT ID: NCT03760302 Completed - Pain, Acute Clinical Trials

Analgesia in ÖAMTC Helicopter Emergency Service in Austria

Start date: December 1, 2018
Phase:
Study type: Observational

A sufficient analgesia in injured or sick people is the main goal of physicians treating a patient. In emergency medicine potent analgesia like ketamine or opioids are routinely used. It is unknown if there are any severe side effects or if the use is safe while in use in a Helicopter Emergency Service equipped with emergency physicians.

NCT ID: NCT03744897 Completed - Pain Perception Clinical Trials

Effect of Hypnosis Combined to Transcranial Direct Stimulation in Pain

Start date: July 18, 2017
Phase: N/A
Study type: Interventional

Pain is a public health condition, which causes great functional disability. Its consequences pervade the personal and social life of the patient, leading to significant changes in their interpersonal relationships, including work, family and social spheres, reducing the ability to perform daily activities. Conventional treatment modalities have been show a very poor therapeutic response, in that most individuals end up becoming polymedicated patients and refractory to treatment. Among non-pharmacological techniques with promising analgesic effects it includes both the hypnotic analgesia and the transcranial stimulation of direct current (tDCS).